Patents by Inventor Ming-Fung Wu

Ming-Fung Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7335640
    Abstract: The invention provides compositions and methods for treatment of sleep disorders. Such methods entail administering to the patient a therapeutically effective dosage regime of an agonist of a hypocretin 1 (Hcrt-1) receptor to a peripheral tissue of the patient, and monitoring the condition of the patient responsive to the treatment, wherein the monitoring indicates a reduction in excessive daytime sleepiness (EDS) and an improvement in nighttime sleep consolidation and architecture. The methods are particularly useful for prophylactic and therapeutic treatment of one or more sleep disorders in a patient.
    Type: Grant
    Filed: July 31, 2006
    Date of Patent: February 26, 2008
    Assignee: The Regents of the University of California
    Inventors: Jerome M. Siegel, Joshi John, Ming-Fung Wu
  • Publication number: 20070010445
    Abstract: The invention provides compositions and methods for treatment of sleep disorders. Such methods entail administering to the patient a therapeutically effective dosage regime of an agonist of a hypocretin 1 (Hcrt-1) receptor to a peripheral tissue of the patient, and monitoring the condition of the patient responsive to the treatment, wherein the monitoring indicates a reduction in excessive daytime sleepiness (EDS) and an improvement in nighttime sleep consolidation and architecture. The methods are particularly useful for prophylactic and therapeutic treatment of one or more sleep disorders in a patient.
    Type: Application
    Filed: July 31, 2006
    Publication date: January 11, 2007
    Applicant: The Regents of the University of California
    Inventors: Jerome Siegel, Joshi John, Ming-Fung Wu
  • Patent number: 7112566
    Abstract: The invention provides compositions and methods for treatment of sleep disorders. Such methods entail administering to the patient a therapeutically effective dosage regime of an agonist of a hypocretin 1 (Hcrt-1) receptor to a peripheral tissue of the patient, and monitoring the condition of the patient responsive to the treatment, wherein the monitoring indicates a reduction in excessive daytime sleepiness (EDS) and an improvement in nighttime sleep consolidation and architecture. The methods are particularly useful for prophylactic and therapeutic treatment of one or more sleep disorders in a patient.
    Type: Grant
    Filed: May 11, 2000
    Date of Patent: September 26, 2006
    Assignee: The Regents of the University of California
    Inventors: Jerome M. Siegel, Joshi John, Ming-Fung Wu